Distillate Capital Partners LLC, an investment management firm, published its second-quarter 2022 investor letter – a copy of which can be downloaded here. Through the sharp sell-off in the first half of 2022, Distillate’s U.S. FSV strategy held up better than the overall market with a decline of 15.80% net of fees vs. a 19.96% decline for the S&P 500 Index. For the same period, Distillate’s Intl. FSV strategy performed roughly in line with the iShares MSCI ACWI ex-US ETF, posting a total return of -18.07% net of fees versus -18.00% for the benchmark. Meanwhile, Distillate’s U.S. SQV’s 2022 first half total return after fees of -17.22% was better than the total return for the iShares Russell 2000 ETF of -23.48% and the iShares Russell 2000 Value ETF’s total return of -17.43%. Go over the fund’s top 5 positions to have a glimpse of its finest picks for 2022.
In its Q2 2022 investor letter, Distillate Capital mentioned UnitedHealth Group Incorporated (NYSE:UNH) and explained its insights for the company. Founded in 1977, UnitedHealth Group Incorporated (NYSE:UNH) is a Minnetonka, Minnesota-based multinational managed healthcare and insurance company with a $480.7 billion market capitalization. UnitedHealth Group Incorporated (NYSE:UNH) delivered a 2.35% return since the beginning of the year, while its 12-month returns are up by 28.35%. The stock closed at $513.94 per share on September 29, 2022.
Here is what Distillate Capital has to say about UnitedHealth Group Incorporated (NYSE:UNH) in its Q2 2022 investor letter:
“UnitedHealth Group was among the 2 largest trims at around 1% each. Each stock was up 1% in the quarter compared to the 16% price decline for the S&P 500 and the positions were reduced as the valuations became somewhat less appealing, though still attractive enough to warrant inclusion.”
Our calculations show that UnitedHealth Group Incorporated (NYSE:UNH) ranks 23rd on our list of the 30 Most Popular Stocks Among Hedge Funds. UnitedHealth Group Incorporated (NYSE:UNH) was in 91 hedge fund portfolios at the end of the second quarter of 2022, compared to 103 funds in the previous quarter. UnitedHealth Group Incorporated (NYSE:UNH) delivered a -0.34% return in the past 3 months.
In September 2022, we also shared another hedge fund’s views on UnitedHealth Group Incorporated (NYSE:UNH) in another article. You can find other investor letters from hedge funds and prominent investors on our hedge fund investor letters 2022 Q2 page.
Disclosure: None. This article is originally published at Insider Monkey.